Structure-Function Correlation in Patients With Central Serous Chorioretinopathy During Initial Disease Activity and After Ten Years
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.11.5 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Judith E Kreminger and 6 co-authors. Institution: Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria. Major MEDLINE topics: Central Serous Chorioretinopathy, Visual Acuity, Visual Fields, Retina. 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To evaluate association of retinal morphological alteration with retinal sensitivity (RS) based on a point-to-point correlation with optical coherence tomography (OCT) and microperimetry in a 10-year follow-up of patients with central serous chorioretinopathy (CSC).
Methods
Macular OCT and microperimetry of patients with an acute CSC episode were acquired prospectively at disease onset and 12 weeks after fluid resorption. Ten years later patients were invited for a cross-sectional follow-up visit including Spectralis-OCT and microperimetry. Multivariable models evaluated point-to-point correlation of RS2 and OCT parameters.
Results
Thirty patients were included in the acute setting and 23 patients were included for the 10-year follow-up. In the acute setting, RS2 is associated with subretinal fluid (SRF; estimate = 37.01; P = 0.014), SRF height (estimate = -32.95; P < 0.001), irregularities in the ellipsoid zone (estimate = -35.28; P < 0.001), and interdigitation zone (estimate = -14.86; P < 0.001), patient age (estimate = -1.26; P = 0.03), and prior photodynamic therapy (estimate = -33.14; P = 0.001). Baseline parameters affecting RS2 after fluid resolution were SRF height (estimate = -11.93; P < 0.001), retinal pigment epithelium (RPE)/Bruch's membrane thickening (estimate = -55.34; P < 0.001), and prior photodynamic therapy (estimate = -118.05; P < 0.001). For the 10 -year follow-up RPE detachment (estimate = -89.02; P < 0.001), RPE atrophy (estimate = -377.14; P < 0.001), female sex (estimate = -81.50; P = 0.014), and prior photodynamic therapy (estimate = -162.18; P < 0.001) were associated with worse RS2.
Conclusions
Long-term functional outcome in CSC is mainly determined by chronic structural damage, especially RPE atrophy and persistent RPE detachment. The association with prior photodynamic therapy reflects disease chronicity rather than treatment-related harm. Early recognition of high-risk morphological features may reduce irreversible functional loss.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
- Vienna Clinical Trial Center, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
- Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Cite
APA
Kreminger, J. E., Iby, J., Baratsits, M., Vilsmeier, J., Gerendas, B. S., Rezar-Dreindl, S., & Sacu, S. (2026). Structure-Function Correlation in Patients With Central Serous Chorioretinopathy During Initial Disease Activity and After Ten Years. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.11.5
Vancouver
Kreminger JE, Iby J, Baratsits M, Vilsmeier J, Gerendas BS, Rezar-Dreindl S, et al. Structure-Function Correlation in Patients With Central Serous Chorioretinopathy During Initial Disease Activity and After Ten Years. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.11.5
BibTeX
@article{Kreminger2026,
author = {Kreminger, Judith E and Iby, Johannes and Baratsits, Magdalena and Vilsmeier, Johannes and Gerendas, Bianca S and Rezar-Dreindl, Sandra and Sacu, Stefan},
title = {Structure-Function Correlation in Patients With Central Serous Chorioretinopathy During Initial Disease Activity and After Ten Years},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.11.5}
}
EUVIMED